Last $3.86 USD
Change Today 0.00 / 0.00%
Volume 0.0
PDII On Other Exchanges
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

pdi inc (PDII) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/6/14 - $6.25
52 Week Low
07/22/14 - $3.86
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PDI INC (PDII)

pdi inc (PDII) Related Bloomberg News

View More Bloomberg News

pdi inc (PDII) Related Businessweek News

No Related Businessweek News Found

pdi inc (PDII) Details

PDI, Inc. provides outsourced commercial services to pharmaceutical, biotechnology, and healthcare companies in the United States. The company’s services offer customers a range of personal and non-personal promotional options for the commercialization of their products throughout the product lifecycles, from development through maturity. It operates in three segments: Sales Services, Marketing Services, and Product Commercialization Services. The Sales Services segment focuses primarily on product detailing, which includes a sales representative meeting face-to-face with targeted physicians and other healthcare decision makers to provide a technical review of the product being promoted and deliver marketing materials, including samples. It also offers a portfolio of sales services consisting of talent acquisition services, short-term teams, and vacancy coverage services. The Marketing Services segment is involved in the creation, design, and implementation of interactive digital communications programs to the healthcare community through the Internet, multimedia, tablet PCs, mobile devices, and dimensional direct mails, as well as DIAGRAM, a proprietary software to deliver digital selling solutions through interactive communications exchanges that accommodate the schedules of healthcare providers. This segment is also engaged in the creation of teledetailing programs executed through tele-representatives. The Product Commercialization Services segment provides product commercialization solutions, including product distribution, product detailing, full supply chain management, operations, sales, marketing, compliance, and regulatory/medical management to pharmaceutical, biotechnology, medical device, and diagnostics clients. PDI, Inc. has a strategic collaboration agreement with Transgenomic, Inc. The company was founded in 1987 and is headquartered in Parsippany, New Jersey.

706 Employees
Last Reported Date: 03/6/14
Founded in 1987

pdi inc (PDII) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $1.0M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $539.4K
President of Sales Services
Total Annual Compensation: $488.5K
Compensation as of Fiscal Year 2013.

pdi inc (PDII) Key Developments

PDI, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

PDI, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenue, net of $32,778,000 against $42,923,000 a year ago. Operating loss was $1,497,000 against operating income of $2,253,000 a year ago. Loss from continuing operations before income tax was $1,514,000 against income from continuing operations before income tax of $2,244,000 a year ago. Loss from continuing operations was $1,580,000 or $0.11 per basic and diluted share against income from continuing operations of $2,180,000 or $0.14 per diluted share a year ago. Net loss was $1,612,000 or $0.11 per basic and diluted share against net income of $2,126,000 or $0.14 per basic and diluted share a year ago. Net cash used in operations was $6,463,000 against net cash provided by operations of $1,222,000 a year ago. Adjusted LBITDA was $350,000 compared to adjusted EBITDA of $2,892,000 a year ago.

PDI, Inc., Annual General Meeting, Jun 04, 2014

PDI, Inc., Annual General Meeting, Jun 04, 2014., at 16:00 Eastern Daylight. Location: Morris Corporate Center One. Agenda: To elect two Class III directors of the company, who will serve for a term of three years; to conduct a nonbinding advisory vote on a resolution approving the compeansation of its named executive officers; to approve an amendment to its amended and restated 2004 stock award and incentive plan increasing the shares authorized for awards there under by 1,250,000; and to ratify the appointment of BDO USA, LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2014; and to transact such other business as may properly come before the annual meeting or any adjournment or postponement thereof.

PDI, Inc. to Report Q1, 2014 Results on May 07, 2014

PDI, Inc. announced that they will report Q1, 2014 results on May 07, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PDII:US $3.86 USD 0.00

PDII Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PDII.
View Industry Companies

Industry Analysis


Industry Average

Valuation PDII Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PDI INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at